Psoriasis-linked gene mutation also impacts gut health 

VIB researchers and colleagues uncover an unexpected role for psoriasis-associated gene CARD14 in intestinal function and disease. 

Ghent, 23 October 2025 – A mutation previously linked to skin disorders like psoriasis may also play a surprising role in gut health, according to new research published by scientists at VIB-UGent and colleagues from UGent, the University of Barcelona, and University College London. This mutation activates skin immune responses but also affects the intestine. This finding, published in EMBO Molecular Medicine, reveals a new connection between genetics, the immune system, and the gut, which may have therapeutical implications.  

Scientists under the leadership of Dr. Inna Afonina and Prof. Rudi Beyaert (VIB-UGent Center for Inflammation Research) have found that a mutation in the gene CARD14, known for activating skin immune responses in psoriasis patients, also affects the intestine. This mutation reduces gut motility, promotes mild inflammation, and increases vulnerability to bacterial infections. 

Using a mouse model that expresses the human psoriasis-associated CARD14 mutation in intestinal epithelial cells (IECs), the researchers found that the mice developed slower intestinal transit despite no damage to the gut lining or enteric nervous system. Such changes in intestinal motility are associated with many diseases. 

“Our study reveals that CARD14’s impact isn’t limited to the skin,” said Aigerim Aidarova (VIB-UGent), lead author of the study. “In the intestine, this mutation leads to subtle but important changes that may contribute to subclinical intestinal symptoms in patients who carry it.” 
Prof. Rudi Beyaert, Dr. Inna Afonina, and Aigerim Aidarova
Prof. Rudi Beyaert, Dr. Inna Afonina, and Aigerim Aidarova

Gut-immune crosstalk 

Further analysis showed that the mutation altered the gene expression profile of IECs, including a drop in antimicrobial peptides produced by Paneth cells – specialized cells critical for gut immunity. Together with changes in the gut microbiome, this decreased antimicrobial production was linked to reduced microbial diversity and a heightened susceptibility to intestinal bacterial infections. ​ 

These findings offer new insight into the crosstalk between genetic immune regulators and gut function, and suggest that psoriasis patients with CARD14 mutations may face previously unrecognized issues that could set the stage for the development of intestinal disease. 

“This research broadens our understanding of how a single genetic variant can influence different organs in the body,” said Prof. Rudi Beyaert. ​ 
“It also provides a valuable animal model to further study gut inflammation and motility disorders,” adds Dr. Inna Afonina. 

The study opens new avenues for investigating the connection between genetics, immune signaling, and gastrointestinal health, with potential therapeutic implications. It also suggests that raising awareness of intestinal disease symptoms among psoriasis patients and dermatologists could be beneficial. 


Publication 

CARD14 signaling in intestinal epithelial cells induces intestinal inflammation and intestinal transit delay. Aidarova et al. 2025. EMBO Molecular Medicine. 

Funding 

This work was supported by FWO, Ghent University, and VIB.


Gunnar De Winter

Gunnar De Winter

Science Communication Manager, VIB

 

Share

Latest stories

Researchers discover clues for Alzheimer’s disease in hibernation

Researchers discover clues for Alzheimer’s disease in hibernation

Leuven, 12 November 2026 – Researchers at VIB and KU Leuven have discovered that hibernation triggers changes in brain cells that partially resemble those in Alzheimer’s disease. Studying golden hamsters, the team identified changes in gene expression across the hibernation cycle, which resemble those associated with the accumulation of amyloid plaques in Alzheimer’s. The findings, published in Science Advances, suggest that some early cellular changes associated with Alzheimer’s may also occur as part of a natural adaptive response, offering new ways to study the disease for therapy development.

press.vib.be

An inside look at a molecular switch that triggers inflammation

An inside look at a molecular switch that triggers inflammation

Ghent, 9 November 2026 – Researchers at VIB and Ghent University have uncovered how an important driver of inflammation is activated at the molecular level. Their findings, published in Science Immunology, also explain how a medicine used to treat a severe form of psoriasis blocks this inflammatory signal.

press.vib.be

Researchers uncover why humans are more sensitive than other species to a brain developmental disease

Researchers uncover why humans are more sensitive than other species to a brain developmental disease

Leuven, 4 November 2026 – Researchers at VIB and KU Leuven have uncovered how mutations in the ASPM gene disrupt the development of neural stem cells that help the human brain grow. This disruption explains how these mutations cause microcephaly, a condition characterized by an abnormally small brain and head, often accompanied by intellectual disability. The discovery, published in Developmental Cell, also sheds light on how differences in brain development can make humans more susceptible to certain genetic conditions than other mammals.

press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be